Results 51 to 60 of about 6,402,628 (197)

Area postrema sündroom. Haigusjuhu kirjeldus [PDF]

Ravile allumatu iiveldus, oksendamine või luksumine võib olla arstile käsitlemiseks keerukas seisund, mille põhjust on raske tuvastada. Piklikajus asuva area postrema piirkonna kahjustusele ei osata sageli mõelda.
Unt, Triin Helin
core   +1 more source

A diagnostic challenge in a young woman with intractable hiccups and vomiting: a case of neuromyelitis optica [PDF]

Journal of Community Hospital Internal Medicine Perspectives, 2015
Intractable nausea and vomiting along with hiccups is a commonly encountered problem on any general medicine or gastroenterology service. These symptoms are usually not appreciated as the possible initial manifestation of neuromyelitis optica (NMO ...
Rohan Mandaliya, Margot Boigon, David G. Smith, Suchit Bhutani, Naveed Ali, Cheryl Hilton, John Kelly, Nataliya Ternopolska   +7 more
doaj   +1 more source

Area Postrema: Fetal Maturation, Tumors, Vomiting Center, Growth, Role in Neuromyelitis Optica.

, 2019
INTRODUCTION The area postrema in the caudal fourth ventricular floor is highly vascular without blood-brain or blood-cerebrospinal fluid barrier. In addition to its function as vomiting center, several others are part of the circumventricular organs for
Flores-Sarnat L, Sarnat HB, Boltshauser E   +2 more
core   +1 more source

Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes

British Journal of Pharmacology, EarlyView.
Abstract Incretin‐based therapies have gained momentum as a key strategy for reducing cardiovascular risk in individuals with obesity and/or type 2 diabetes (T2D). It remains unclear whether the cardiovascular benefits reflect a direct reduction in atherogenic lipoproteins—namely, low‐density lipoproteins (LDL), very low‐density lipoproteins (VLDL) and
Andrea Baragetti, Giuseppe Danilo Norata
wiley   +1 more source

Ravulizumab for relapse prevention in AQP4-IgG–positive neuromyelitis optica spectrum disorder: a 2-year follow-up case report

Frontiers in Medicine
BackgroundNeuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease of the central nervous system, distinct from multiple sclerosis, characterized by severe inflammatory attacks targeting the optic nerves, spinal cord, and brainstem ...
Nabil Akkawi, Elkhansa Hassabo Mohamed, Ahmed Shatila   +2 more
doaj   +1 more source

Amylin analogues as a novel perspective in anti‐obesity therapy

British Journal of Pharmacology, EarlyView.
Abstract Public health systems face a major challenge because of the worldwide obesity epidemic. The number of obese individuals has increased dramatically and, even in Switzerland which may be considered a relatively “lean” country, the numbers are alarmingly high and have reached almost 50% of the adult population.
Thomas A. Lutz
wiley   +1 more source

Area postrema syndrome in aquaporin-4-positive neuromyelitis optica spectrum disorder: clinical and imaging correlation: three case presentations

The Egyptian Journal of Radiology and Nuclear Medicine
Background Area postrema syndrome (APS), characterized by persistent nausea, vomiting, and hiccups, is a distinctive but often under-recognized manifestation of neuromyelitis optica spectrum disorder (NMOSD). Owing to the absence of a blood–brain barrier
Virendra Kumar Meena, Yamini Hatwal, Jaya Pamnani, Vinod Kumar Mehta, Ravinder Kumar Kundu   +4 more
doaj   +1 more source

Meningitis as a recurrent manifestation of anti-AQP4/anti-MOG negative neuromyelitis optica spectrum disorder: a case report

BMC Neurology, 2021
Background Neuromyelitis optica spectrum disorders (NMOSD), a group of autoimmune neurological diseases, involve the optic nerve, spinal cord, and brain. Meningitis is rarely reported as the primary clinical manifestation of both anti-aquaporin-4 (AQP4)/
Chenyang Zhang, Kang Zhang, Bing Chen, Jiao Yin, Miaomiao Dong, Yixin Qin, Xiao Yang   +6 more
doaj   +1 more source

Clinical Profile and Treatment Outcome in MOGAD: A Single-Center Case-Series Study in Guiyang, China

Frontiers in Neurology, 2022
BackgroundThe clinical spectrum of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is expanding over time. However, the long-term management and prognosis of this disorder are still controversial.
Xiaoyang Lei, Shipeng Guo, Shengnan Cui, Yin Pu, Anni Zhang, Dian He   +5 more
doaj   +1 more source

Therapeutic access points: The roles of circumventricular organs in drug delivery and metabolic regulation

British Journal of Pharmacology, EarlyView.
The current obesity drug landscape, dominated by GLP‐1 receptor agonists and emerging multi‐agonist therapies, has reinforced that long‐term weight loss is achieved in large part through central mechanisms that suppress appetite and reshape energy balance.
Ines Martinez‐Corral, Nicholas Monaco, Daniel I. Brierley, Monica Imbernon   +3 more
wiley   +1 more source